↓ Skip to main content

Perazine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

twitter
3 X users
facebook
1 Facebook page
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
221 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Perazine for schizophrenia
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd002832.pub3
Pubmed ID
Authors

Stefan Leucht, Bartosz Helfer, Benno Hartung

Abstract

Perazine is an old phenothiazine derivative used for the treatment of people with schizophrenia and is reputed to have a low level of extrapyramidal adverse effects. As far as we are aware, its use is limited to Germany, Poland, the former Yugoslavia and the Netherlands.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 221 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 220 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 33 15%
Student > Master 33 15%
Student > Ph. D. Student 22 10%
Researcher 20 9%
Student > Bachelor 16 7%
Other 44 20%
Unknown 53 24%
Readers by discipline Count As %
Medicine and Dentistry 61 28%
Unspecified 33 15%
Psychology 20 9%
Nursing and Health Professions 17 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Other 22 10%
Unknown 58 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2019.
All research outputs
#7,336,958
of 25,738,558 outputs
Outputs from Cochrane database of systematic reviews
#8,837
of 13,137 outputs
Outputs of similar age
#83,728
of 338,897 outputs
Outputs of similar age from Cochrane database of systematic reviews
#183
of 252 outputs
Altmetric has tracked 25,738,558 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 13,137 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 338,897 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 252 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.